Jazz Pharma director plans $942K stock sale

Jazz Pharmaceuticals plc (JAZZ) director Mary Elizabeth Henderson filed a Form 144 indicating an intention to sell 3,852 shares of JAZZ common stock through E*TRADE Financial Corporation on NASDAQ.

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc (JAZZ) director Mary Elizabeth Henderson filed a Form 144 indicating an intention to sell 3,852 shares of JAZZ common stock through E*TRADE Financial Corporation on NASDAQ. The shares are related to restricted stock vesting on 08/28/2026, with an estimated aggregate market value of $941,968.

Key Figures

Shares proposed to be sold: 3,852 shares of common stock Aggregate market value: $941,968 Proposed sale date: 08/31/2026 +1 more

4 metrics

Shares proposed to be sold 3,852 shares of common stock Securities Information section for Jazz Pharmaceuticals plc

Aggregate market value $941,968 Estimated value of the 3,852 common shares to be sold

Proposed sale date 08/31/2026 Date associated with the proposed sale of common shares

Restricted stock vesting date 08/28/2026 Vesting date for restricted stock underlying the shares to be sold

Key Terms

Rule 144, restricted stock vesting, Form 144, power of attorney

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"COMMON | 08/28/2026 | RESTRICTED STOCK VESTING | ISSUER"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Form 144 regulatory

"144: Filer Information 144: Issuer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

power of attorney regulatory

"Signature | /s/Paz Dizon by power of attorney for Mary Elizabeth"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for JAZZ by Mary Elizabeth Henderson disclose?

It discloses that director Mary Elizabeth Henderson plans to sell 3,852 shares of Jazz Pharmaceuticals plc common stock, related to restricted stock vesting, with an estimated aggregate market value of $941,968 and a proposed sale date of 08/31/2026.

How many JAZZ shares are covered by Mary Elizabeth Henderson’s Form 144?

The Form 144 covers a proposed sale of 3,852 shares of Jazz Pharmaceuticals plc common stock. These shares are connected to restricted stock vesting recorded with a vesting date of 08/28/2026.

What is the estimated value of the JAZZ shares in this Form 144 filing?

The filing lists an estimated aggregate market value of $941,968 for the 3,852 Jazz Pharmaceuticals plc common shares proposed to be sold, as shown in the securities information section.

When are the JAZZ shares in this Form 144 expected to be sold?

The proposed sale date for the Jazz Pharmaceuticals plc shares is listed as 08/31/2026. The related restricted stock vesting event is dated 08/28/2026 in the securities to be sold section.

What is the source of the JAZZ shares being sold under this Form 144?

The shares are described as COMMON stock arising from RESTRICTED STOCK VESTING with an issuer-related transaction type of Compensation, and a vesting date of 08/28/2026.

Which broker is listed for the proposed JAZZ share sale in the Form 144?

The broker listed is ETRADE FINANCIAL CORPORATION, located at 3 Edison Drive, Alpharetta, GA 30005, for the proposed sale of Jazz Pharmaceuticals plc common stock on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/31/2026 - 03:50 PM EDT Accepted by SEC EDGAR 08/31/2026 - 03:50 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001989533
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Jazz Pharmaceuticals plc
SEC File Number	001-33500
Address of Issuer	FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN IRELAND D04 E5W7
Phone	353-1-634-7800
Name of Person for Whose Account the Securities are To Be Sold	Henderson Mary Elizabeth
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	ETRADE FINANCIAL CORPORATION 3 EDISON DRIVE ALPHARETTA GA 30005	3852	941968.00	64914577	08/31/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	08/28/2026	RESTRICTED STOCK VESTING	ISSUER			3852	08/28/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Paz Dizon by power of attorney for Mary Elizabeth Henderson
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)